Rapport Therapeutics Inc (RAPP) Unusual Options Activity Today

Checking RAPP unusual options activity helps you spot when traders are making outsized bets on Rapport Therapeutics Inc before the broader market catches on. Rapport Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor RAPP unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching RAPP unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking RAPP unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and RAPP unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders.

The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.

Catalysts rarely arrive without a footprint, and RAPP unusual options activity is often where that footprint shows up first. Our scanner tracks Rapport Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at RAPP unusual options volume on the call side or chasing put sweeps, Rapport Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.